[TVTX] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
24-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- -42.61%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 212,018 227,490 198,321 175,338 164,246 154,937 133,591 7.99%
PBT -278,169 -179,682 -188,790 -146,448 -101,867 -58,363 -57,582 30.00%
Tax 313 409 -19,359 -21 811 1,368 -9,679 -
NP -278,482 -180,091 -169,431 -146,427 -102,678 -59,731 -47,903 34.07%
Tax Rate - - - - - - - -
Total Cost 490,500 407,581 367,752 321,765 266,924 214,668 181,494 18.01%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -131.35 -79.16 -85.43 -83.51 -62.51 -38.55 -35.86 24.14%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -4.37 -3.01 -3.56 -3.46 -2.54 -1.54 -1.29 22.53%
EPS Diluted -4.37 -3.01 -3.56 -3.46 -2.54 -1.54 -1.25 23.18%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.